United States · FDA National Drug Code directory

Phenazopyridine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
70518-3975_5796d1de-ee8d-ba66-e063-6294a90afca2
Product NDC
70518-3975
Form
TABLET
Composition / generic term
Phenazopyridine Hydrochloride
Labeler
REMEDYREPACK INC.
Marketing category
UNAPPROVED DRUG OTHER
Marketing start / end (source format)
20240106
Source listing expiry
20271231

Source-listed ingredients

  • PHENAZOPYRIDINE HYDROCHLORIDE — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BLISTER PACK (70518-3975-0) · 70518-3975-0
  • 9 TABLET in 1 BOTTLE, PLASTIC (70518-3975-2) · 70518-3975-2
  • 6 TABLET in 1 BOTTLE, PLASTIC (70518-3975-3) · 70518-3975-3
  • 50 POUCH in 1 BOX (70518-3975-4) / 1 TABLET in 1 POUCH (70518-3975-5) · 70518-3975-4
  • 100 POUCH in 1 BOX (70518-3975-6) / 1 TABLET in 1 POUCH (70518-3975-5) · 70518-3975-6

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →